Neumora Therapeutics Cash Flow Statement (2022-2026) | NMRA

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -29.20M-28.43M-35.60M-38.54M-53.03M-108.46M-53.72M-58.70M-72.55M-58.82M-67.99M-52.73M-56.76M-59.45M-53.46M
Share-based Compensation (Quarter) 2.10M2.79M2.19M2.54M6.45M6.05M7.37M12.77M9.95M9.90M9.32M7.17M5.98M7.41M7.41M
Gains from Sales and Divestitures (Quarter) 1.91M2.49M0.19M0.46M0.09M0.09M0.03M0.37M0.37M0.07M0.01M
Gains from Investment Securities (Quarter) -0.30M-0.01M-0.03M0.38M0.25M0.88M0.40M0.41M3.44M13.61M-0.09M32.45M
Asset Writedowns and Impairment (Quarter) 0.22M
Non-cash Items (Quarter) 24.09M3.26M146.97M90.74M3.75M4.73M44.95M6.49M7.22M7.58M2.71M10.46M
Cash from Operations (Quarter) -30.37M-33.04M-31.02M-47.77M-51.44M-42.95M-56.16M-33.48M-50.34M-59.45M-52.40M-46.63M-47.95M-46.40M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.15M0.16M0.17M0.17M0.20M0.16M0.16M0.16M0.16M0.16M0.02M0.02M0.01M0.01M
Change in Working Capital
Change in Account Payables (Quarter) -3.11M-6.01M7.04M0.31M-1.91M1.16M-0.41M5.03M-2.90M-2.25M-0.41M-0.10M2.83M1.68M
Change in Accured Expenses (Quarter) 7.03M-0.74M3.12M6.26M-2.16M-4.11M1.94M7.58M1.83M1.68M-6.33M4.87M3.98M-4.02M
Investing Activities
Capital Expenditures (Quarter) 0.48M0.04M0.04M-0.03M
Sales of Property, Plant and Equipment (Quarter) 0.08M0.09M0.03M0.07M
Change in Acquisitions & Divestments (Quarter) 40.09M44.34M38.38M36.58M
Cash from Investing Activities (Quarter) -8.03M2.82M24.08M23.82M13.68M-150.00M21.25M156.99M-98.80M44.16M30.40M51.32M42.65M0.07M
Financing Activities
Other financing activities (Quarter) 0.15M-0.21M0.01M0.11M23.45M0.82M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) -0.14M38.90M
Change in Capital Stock
Shares Issued (Quarter) -1.00M0.60M0.40M1.51M230.05M1.84M-1.84M7.48M0.06M-0.06M
Preferred Shares Issued (Quarter) 77.22M
Misc.
Cash from Financing Activities (Quarter) 26.83M0.10M0.29M232.02M-0.48M1.84M2.65M1.53M15.57M18.46M-0.14M58.77M10.88M
Change in Cash (Quarter) -11.56M-30.12M-6.65M208.07M-38.25M-191.11M-32.25M125.04M-133.57M-15.29M-3.55M4.55M53.46M-35.46M
Free Cash Flow (Quarter) -30.85M-33.08M-31.02M-47.81M-51.41M-42.95M-56.16M-33.48M-50.34M-59.45M-52.40M-46.63M-47.95M-46.40M
Net Cash Flow (Quarter) -11.56M-30.12M-6.65M208.07M-38.25M-191.11M-32.25M125.04M-133.57M-15.29M-3.55M4.55M53.46M-35.46M